Human Insulin

FDA Drug Profile — Novolin R, Novolin 70/30, Novolin N

Drug Details

Generic Name
Human Insulin
Brand Names
Novolin R, Novolin 70/30, Novolin N
Application Number
BLA019938
Sponsor
Novo Nordisk
NDC Codes
8
Dosage Forms
INJECTION, SOLUTION, INJECTION, SUSPENSION
Routes
SUBCUTANEOUS
Active Ingredients
INSULIN HUMAN

Indications and Usage

1 INDICATIONS AND USAGE NOVOLIN N is indicated to improve glycemic control in adults and pediatric patients with diabetes mellitus. NOVOLIN N is an intermediate-acting human insulin indicated to improve glycemic control in adults and pediatric patients with diabetes mellitus. ( 1 )